Purchase Order 75N93023P01107
Award Date
8/18/23
Potential Completion Date
11/30/23
Potential Value
$25K
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $12,500 purchase order to Oxford Nanopore Technologies Inc. for an annual software and device warranty for GridION DNA sequencing instruments. The contract period is from September 1, 2023 through August 31, 2024. Oxford Nanopore Technologies Inc. will provide the warranty services for the GridION instruments under a firm fixed price contract. The place...
This $6,678 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company that develops and provides nanopore-based electronic DNA/RNA sequencing systems. The award does not have a set-aside designation. Through this contract, Oxford Nanopore is providing its next-generation sequencing equipment, consumables, and...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $101,655.00 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for a Nanopore Technology Sequencing Instrument. The contract has no set-aside designation and was awarded on September 26, 2019, with a completion date of October 31, 2019. Oxford Nanopore Technologies Inc. is a division of Oxford Nanopore Technologies PLC,...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, is for the provision of the company's MinION sequencing device and associated supplies. The $24,999.00 firm fixed-price Purchase Order was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), and does not have a set-aside designation. Oxford Nanopore's innovative nanopore-based sequencing platforms,...
The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $24,264 purchase order to Oxford Nanopore Technologies Inc. for the delivery of unspecified products or services. Performance will take place in New York, NY under a firm fixed price arrangement concluding on September 29, 2023. As the NIH/NHGRI supports genomic research to analyze DNA and interpret the book of life, this contract is likely to provide Oxford Nanopore's...
This is a $95,435 firm-fixed-price purchase order (contract) awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the supply of NANOPORE - GRIDION, a next-generation genomic sequencing platform. There is no set-aside designation associated with this award. Oxford Nanopore Technologies Inc. has...
This is a $21,835.00 firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The purpose of the award is to provide a reagent needed by Shelise Brooks for the preparation of direct RNA libraries for sequencing on the Oxford Nanopore Promethion system in support of the Collins NF_Isletbetacells project led by Dr. Mike Erdos at NHGRI. The contract...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $12,500.00 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for a 12-month software license and device warranty on a GridION system. The award period runs from August 9, 2021, to August 8, 2022, and does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of nanopore-based...
The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $35,000 firm fixed price purchase order to Oxford Nanopore Technologies Inc. for a software license and device warranty to support the Oxford Nanopore Promethion 24A sequencing platform. The contract has a period of performance from January 19, 2024 through January 19, 2025. Oxford Nanopore Technologies Inc. will deliver the requested products and services as the prime...
This is a $243,996.00 firm-fixed price purchase order awarded by the National Institute on Aging, a component of the National Institutes of Health, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the provision of reagents to be used in long-read DNA and RNA sequencing on Oxford Nanopore's proprietary sequencing platforms at the Center for Alzheimer's Disease and Related Dementias. This requirement was originally market researched...